Ernexa Therapeutics Inc.: Form 8-K, filed Jul 7, 2010
Filed with the SEC on Jul 7, 2010 and accepted by EDGAR at Jul 7, 2010, 09:22 ET.
Items reported
- Item 5.02 Departure or appointment of officers or directors
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001019687-10-002541. Last ingested by Listed: Nov 6, 2026, 17:52 ET. Listed shows no prices and gives no investment advice.